Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Chengdu Second People׳s Hospital, Chengdu, Sichuan, China.
J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118792. doi: 10.1016/j.jep.2024.118792. Epub 2024 Sep 7.
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus, mainly manifested as paresthesia. Tangzu granule (TZG) is derived from famous traditional Chinese medicine decoctions and optimized by long-term temporary practice. TZG has good efficacy in improving numbness, pain and pruritus of the lower extremities of DPN patients. However, the overall regulatory mechanisms underlying its effects on DPN remain unclear.
This study aims to explore the potential mechanism of TZG for treating DPN.
Sprague-Dawley (SD) rats were used to establish an in vivo model of DPN with streptozotocin (STZ) injection and high-fat diet (HFD) feeding. Additionally, sciatic glial RSC96 cells were induced with high glucose in vitro. SD rats in intervention group received TZG treatment for 12 weeks. After 12 weeks of treatment, sciatic nerve function was evaluated by intelligent hot plate meter and neuro electrophysiology detector. The morphological changes of sciatic nerve cells were observed by hematoxylin-eosin staining and transmission electron microscope. IL-1β, IL-18 inflammatory cytokines, pyroptosis and P2X7R/NLRP3 signaling pathway were observed by Western blotting, immunofluorescence staining and ELISA.
TZG improved nerve conduction velocity and sciatic neuropathy rational structural changes in DPN rats. It also inhibited RSC96 inflammatory response and cell death that induced by high glucose. This may be related to TZG inhibiting P2X7R, decreasing the activation of NLRP3 inflammasomes, down-regulating the levels of pyroptosis proteins such as caspase-1, cleaved caspase-1, gasdermin D (GSDMD), and GSDMD-N, and inhibiting the release of interleuki (IL)-18 and IL-1β inflammatory cytokines.
TZG inhibited pyroptosis through P2X7R/NLRP3 signaling pathway, alleviated neuroinflammation, and showed protective effect in the treatment of DPN.
糖尿病周围神经病变(DPN)是糖尿病的一种常见并发症,主要表现为感觉异常。糖足逐瘀颗粒(TZG)源自著名的中药方剂,并经过长期的临时实践进行了优化。TZG 对改善 DPN 患者下肢麻木、疼痛和瘙痒有良好的疗效。然而,其对 DPN 影响的整体调节机制尚不清楚。
本研究旨在探讨 TZG 治疗 DPN 的潜在机制。
使用链脲佐菌素(STZ)注射和高脂饮食(HFD)喂养建立 Sprague-Dawley(SD)大鼠体内 DPN 模型。此外,体外诱导坐骨神经胶质 RSC96 细胞高糖。干预组 SD 大鼠给予 TZG 治疗 12 周。治疗 12 周后,使用智能热板仪和神经电生理检测仪评估坐骨神经功能。通过苏木精-伊红染色和透射电镜观察坐骨神经细胞的形态变化。通过 Western blot、免疫荧光染色和 ELISA 观察 IL-1β、IL-18 炎症细胞因子、细胞焦亡和 P2X7R/NLRP3 信号通路。
TZG 改善了 DPN 大鼠的神经传导速度和坐骨神经病变的结构变化。它还抑制了高糖诱导的 RSC96 炎症反应和细胞死亡。这可能与 TZG 抑制 P2X7R、减少 NLRP3 炎性小体的激活、下调细胞焦亡蛋白如 caspase-1、cleaved caspase-1、gasdermin D(GSDMD)和 GSDMD-N 的水平以及抑制白细胞介素(IL)-18 和 IL-1β 炎症细胞因子的释放有关。
TZG 通过 P2X7R/NLRP3 信号通路抑制细胞焦亡,减轻神经炎症,在治疗 DPN 中表现出保护作用。